BioPharmSignal logoBioPharmSignal

Biotech News

Progyny Commemorates 10 Years of Redefining Women’s Health and Family Building Care

Progyny (PGNY)ProgynyPartnership

Throughout 2026, in partnership with members, providers, and employers, Progyny will highlight a decade of innovation, expanded access, and industry-leading outcomes. NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- Over the past ten years, millions of individuals and families have gained access to

Related news

PGNYProgyny2026-04-16 13:06 EST

Progyny Expands Access to Fertility and Women’s Health with Industry’s First Fully Insured Supplemental Plan

PGNYProgyny2026-05-11 14:57 EST

Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference

DAREDare Bioscience, Inc.2019-10-07 12:00 EST

Daré Bioscience to Present an Overview on its Intravaginal Ring (IVR) Technology in Development for Sustained-Release Hormone Therapy and Pregnancy Maintenance at the 9th Annual Partnership Opportunities in Drug Delivery Conference

MGRXMANGOCEUTICALS2025-12-19 12:30 EST

Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy

FEMYFEMASYS2026-01-13 14:00 EST

Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care

FEMYFEMASYS2026-04-16 13:00 EST

Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio

View all latest news

Progyny

Women's Health and Family Building Progyny manages employer-sponsored benefits for fertility, family building and women's health. Its programs are designed to guide members through complex care while helping benefit purchasers manage quality and cost. Integrated Benefit Platform The company's services include fertility treatment,...

Recent company news

PGNYProgyny2026-08-07 14:51 EST

Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference

PGNYProgyny2026-08-06 20:01 EST

Progyny, Inc. Announces Second Quarter 2026 Results

PGNYProgyny2026-07-23 19:30 EST

Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report

PGNYProgyny2026-05-28 13:04 EST

New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System

PGNYProgyny2026-05-26 12:00 EST

Progyny, Inc. Announces Share Repurchase Program

Stock data

Close
30.21 USD
Market cap
1.97B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States